Agennix AG
Country
Germany
Краткое название
Agennix AG
Headquarters
Im Neuenheimer Feld 515
Members of the board
Torsten Hombeck, Ph.D. — Senior Vice President, Chief Financial Officer
Rajesh Malik, M.D. — Senior Vice President, Chief Medical Officer
Christine Boisclair — Senior Vice President, Global Regulatory Affairs
Colin Freund — Senior Vice President & Chief Business Officer
Greg Hamm — Senior Vice President, Human Resources & Corporate Integration
Brent Hatzis-Schoch — Senior Vice President & General Counsel
Jill Porter, Ph.D. — Senior Vice President, Pharmaceutical Development
Rajesh Malik, M.D. — Senior Vice President, Chief Medical Officer
Christine Boisclair — Senior Vice President, Global Regulatory Affairs
Colin Freund — Senior Vice President & Chief Business Officer
Greg Hamm — Senior Vice President, Human Resources & Corporate Integration
Brent Hatzis-Schoch — Senior Vice President & General Counsel
Jill Porter, Ph.D. — Senior Vice President, Pharmaceutical Development
Categories medicine
Oncology, Endocrinology
Stage of the project
Production
Disease
Lung cancer
Ticker
GAGXF
Current owners
Christof Hettich, Ph.D., L.L.D. — Chairman
Frank Young, M.D., Ph.D. — Vice Chairman
Friedrich von Bohlen und Halbach, Ph.D.
Alan Feinsilver
Bernd R. Seizinger, M.D., Ph.D.
James D. Weaver III
Frank Young, M.D., Ph.D. — Vice Chairman
Friedrich von Bohlen und Halbach, Ph.D.
Alan Feinsilver
Bernd R. Seizinger, M.D., Ph.D.
James D. Weaver III
Technology
Other, Cell Technologies, Technologies, Pharmaceuticals, Chemistry